AaВерсия для слабовидящих
EN

Scientific papers

FSBI ‘SCEEMP’ researchers and experts contributed to 738 scientific papers during the period from 2017 to 2021, of which 308 papers are indexed in Scopus and Web of Science international databases. The results of research performed at FSBI ‘SCEEMP’ were also reflected in 14 monographs and 23 course manuals.

For more details on the FSBI ‘SCEEMP’ publication activity please consult the official resources:  

RSCI

Scopus

The most significant publications by FSBI ‘SCEEMP’ experts during the period 2017–2022


  1. Zhuravleva MV, Gorodetskay GI, Reznikova TS, Vasyukova NS, Arkhipov VV, Serebrova SY. Meta-analytical evaluation of the clinical efficacy of a complex metabolic neuroprotector in patients with chronic cerebral ischemia. Antibiot Chemother. 2022;66(9–10):39–53. doi:10.37489/0235-2990-2021-66-9-10-39-53
  2. Kuz’mina NE, Moiseev SV, Luttseva AI. NMR Spectroscopy Study of Enol–Enol Tautomerism of Nitisinone in Solutions. Pharm Chem J. 2021; 55(4):396-401. doi:10.1007/s11094-021-02434-9
  3. Romanov B.K. Coronavirus disease COVID-2019. Safety and Risk of Pharmacotherapy. 2020;8(1):3-8. (In Russ.) doi:10.30895/2312-7821-2020-8-1-3-8
  4. Gorenkov D.V., Khantimirova L.M., Shevtsov V.A., Rukavishnikov A.V., Merkulov V.A., Olefir Yu.V. An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare. BIOpreparations. Prevention, Diagnosis, Treatment. 2020;20(1):6-20. (In Russ.) doi:10.30895/2221-996X-2020-20-1-6-20
  5. Chaplenko AA, Monogarova OV, Oskolok KV. Digital Colorimetry of Non-steroidal Anti-inflammatory Drugs: Identification Using Principal Component Method. Drug Dev Regist. 2020;9(1):55–59. doi:10.33380/2305-2066-2020-9-1-55-59
  6. Kukes VG, Parfenova OK, Romanov BK, и др. The Mechanism of Action of Ethoxidol on Oxidative Stress Indices in Heart Failure and Hypotension. Sovrem Tehnol v Med. 2020;12(2):67. doi:10.17691/stm2020.12.2.08
  7. Koshechkin K, Lebedev G, Tikhonova J. Regulatory Information Management Systems, as a Means for Ensuring the Pharmaceutical Data Continuity and Risk Management. В: Smart Innovation, Systems and Technologies. 2020:265–274. doi:10.1007/978-981-13-8311-3_23
  8. Shchukin VM, Zhigilei ES, Erina AA, Shvetsova YN, Kuz’mina NE, Luttseva AI. Validation of an ICP-MS Method for the Determination of Mercury, Lead, Cadmium, and Arsenic in Medicinal Plants and Related Drug Preparations. Pharm Chem J. 2020;54(9):968–976. doi:10.1007/s11094-020-02306-8
  9. Starchak YA, Gavrilin MV, Shineva NV. Transfer of Analytical Procedures (Review). Drug Dev Regist. 2020;9(3):182–187. doi:10.33380/2305-2066-2020-9-3-182-187
  10. Zhuravleva MV,  Romanov BK,  Gorodetskaya GI,  Muslimova OV,  Krysanova VS, Demchenkova EYu. Topical issues of drug safety, possibilities of improving of pharmacovigilance. Safety and Risk of Pharmacotherapy. 2019;7(3):109–119. (In Russ.) doi:10.30895/2312-7821-2019-7-3-109-119
  11. Yunasova TN, Gorenkov DV, Rukavishnikov AV, Movsesyants AA, Merkulov VA. Analysis of measles incidence in Russia and problems of measles prevention at the elimination stage. BIOpreparations. Prevention, Diagnosis, Treatment. 2019;19(3):154–160. (In Russ.) doi:10.30895/2221-996X-2019-19-3-154-160
  12. Prokopov IA, Kovaleva EL, Minaeva ED, et al. Animal-derived medicinal products in Russia: Current nomenclature and specific aspects of quality control. J Ethnopharmacol. 2019;240:111933. doi:10.1016/j.jep.2019.111933
  13. Engalycheva G.N., Syubaev R.D., Goryachev D.V. Quality Standards of Preclinical Pharmacological Studies. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2019;9(4):248-255. (In Russ.) doi:10.30895/1991-2919-2019-9-4-248-255
  14. Movsesyants A.A., Olefir Yu.V. Current Challenges of Preventive Vaccination Against Rabies. BIOpreparations. Prevention, Diagnosis, Treatment. 2019;19(1):10-16. (In Russ.) doi:10.30895/2221-996X-2019-19-1-10-16
  15. Khorol’skii MD, Anan’ina OV, Chaplenko AA, Nedkov IV, Maslennikova NV, Ramenskaya GV. Comparison of Approaches to Determining N-Nitrosodimethylamine Impurity in Valsartan Drug Substance By GC-MS Methods. Pharm Chem J. 2019;53(8):766–770. doi:10.1007/s11094-019-02076-y
  16. Soldatov AA, Avdeeva JI, Kryuchkov NA, Skosyreva ES. Safety concerns of biosimilar hormone products. Curr Med Res Opin. 2019;35(6):1003–1009. doi:10.1080/03007995.2018.1552041
  17. Fadeikina OV, Volkova RA, Karpova EV. Statistical Analysis of Results from the Attestation of Biological Standard Samples: Use of the Mann-Whitney Test. Pharm Chem J. 2019;53(7):655–659. doi:10.1007/s11094-019-02057-1
  18. Olefir YV, Sakanyan EI, Shishova LI, Senchenko SP. Pharmacopoeial Quality Requirements for Medicinal Products. Pharm Chem J. 2019;52(11):936–941. doi:10.1007/s11094-019-01929-w
  19. Solovyova A.P., Goryachev D.V., Arkhipov V.V. Criteria for Assessment of Cognitive Impairment in Clinical Trials. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2018;8(4):218-230. (In Russ.) doi:10.30895/1991-2919-2018-8-4-218-230
  20. Velts N.Yu., Zhuravleva E.O., Bukatina T.M., Kutekhova G.V. Nonsteroidal anti-inflammatory drugs: problems of safe use. Safety and Risk of Pharmacotherapy. 2018;6(1):11-18. (In Russ.) doi:10.30895/2312-7821-2018-6-1-11-18
  21. Rumyantsev NA, Kukes VG, Kazakov RE, Rumyantsev AA, Sychev DA. Use of pharmacogenetic testing to prevent adverse drug reactions during statin therapy. Therapeutic Archive. 2017;89(1):82–87. (In Russ.) doi:10.17116/terarkh201789182-87
  22. Kareva EN, Serebrova SYu. Challenges in drug treatment of gastric motility disorders (Review). Experimental and Clinical Gastroenterology. 2017;7(143):167–183. (In Russ.)
  23. Fadeikina OV, Volkova RA. Elaboration of Certification Procedures for Reference Standards of Biological Drugs. Pharm Chem J. 2017;51(8):716–721. doi:10.1007/s11094-017-1680-6